The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease
Open accessAbstract
BACKGROUND: Nitric oxide (NO) is involved in inflammation and host defence of the lung. It has been found in increased concentrations in the airways in asthmatic subjects but its levels in patients with chronic obstructive pulmonary disease (COPD) have not been investigated. A study was undertaken to determine whether markers of NO metabolism (NO in exhaled air, iNOS expression in sputum cells, and nitrite + nitrate (NO2-/NO3-) in sputum supernatant) are increased in subjects with COPD, and whether they correlate with inflammatory indices in induced sputum. The associations of these markers with smoking were also assessed. METHODS: Sixteen subjects with COPD (median age 66 years, median forced expiratory volume in one second (FEV1) 63% predicted, eight current smokers) and 16 healthy subjects (median age 63 years, median FEV1 113% predicted, eight current smokers) participated in the study. NO was measured during tidal breathing and sputum was induced by inhalation of hypertonic saline. RESULTS: No differences were observed between subjects with COPD and healthy controls in exhaled NO excretion rate (median 5.15 and 6.25 nmol/min), sputum macrophage iNOS expression (14% and 12%), and sputum supernatant NO2-/NO3- (46 and 73 microM). NO in exhaled air correlated with the percentage of sputum eosinophils in patients with COPD (rho = 0.65, p = 0.009) but not in healthy individuals. Exhaled NO and supernatant NO2-/NO3- levels were lower in healthy smokers than in healthy non/ex-smokers. CONCLUSIONS: Our findings indicate that NO metabolism is not increased in patients with stable COPD. The close association between exhaled NO levels and sputum eosinophils suggests a role for NO in airway inflammation in COPD. Studies performed during exacerbations may clarify this role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased amount of nitric oxide in exhaled air of asthmatics
Alving, K., Weitzberg, E., & Lundberg, J. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06091368 · Cited by 1,232
The biology of nitrogen oxides in the airways
Gaston, B., Drazen, J. M., Loscalzo, J., & Stamler, J. S. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.7508323 · Cited by 918
Cited by
Nitric oxide in health and disease of the respiratory system
Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) · Physiological Reviews · doi:10.1152/physrev.00034.2003 · Cited by 903
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Exhaled Markers of Pulmonary Disease
KHARITONOV, S. A., & BARNES, P. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2009041 · Cited by 844
Mediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Kirkham, P. A., & Barnes, P. J. (2013) · Chest · doi:10.1378/chest.12-2664 · Cited by 685
Oxidative stress and lung inflammation in airways disease
MacNee, W. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01320-6 · Cited by 556
Exhaled nitric oxide measurements: clinical application and interpretation
Taylor, D. R., Pijnenburg, M. W., Smith, A. D., & Jongste, J. C. D. (2006) · Thorax · doi:10.1136/thx.2005.056093 · Cited by 507
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Siva, R., Green, R. H., Brightling, C. E., Shelley, M., Hargadon, B., McKenna, S., Monteiro, W., Berry, M., Parker, D., Wardlaw, A. J., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146306 · Cited by 453
Willemse, B. W. M., Postma, D. S., Timens, W., & ten Hacken, N. H. T. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00012704 · Cited by 433
Self-citationPulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease
MacNee, W. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200411-056sf · Cited by 411
Multiple roles of nitric oxide in the airways
Ricciardolo, F. L. M. (2003) · Thorax · doi:10.1136/thorax.58.2.175 · Cited by 370
Increase in Reactive Nitrogen Species Production in Chronic Obstructive Pulmonary Disease Airways
ICHINOSE, M., SUGIURA, H., YAMAGATA, S., KOARAI, A., & SHIRATO, K. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9908132 · Cited by 347
Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease
MAZIAK, W., LOUKIDES, S., CULPITT, S., SULLIVAN, P., KHARITONOV, S. A., & BARNES, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.97-05009 · Cited by 324
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Barnes, P. J., Chowdhury, B., Kharitonov, S. A., Magnussen, H., Page, C. P., Postma, D., & Saetta, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1659pp · Cited by 298
Self-citationExhaled Ethane, a Marker of Lipid Peroxidation, Is Elevated in Chronic Obstructive Pulmonary Disease
PAREDI, P., KHARITONOV, S. A., LEAK, D., WARD, S., CRAMER, D., & BARNES, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909025 · Cited by 297
Biomarkers of some pulmonary diseases in exhaled breath
Kharitonov, S. A., & Barnes, P. J. (2002) · Biomarkers · doi:10.1080/13547500110104233 · Cited by 290
PAPI, A., ROMAGNOLI, M., BARALDO, S., BRACCIONI, F., GUZZINATI, I., SAETTA, M., CIACCIA, A., & FABBRI, L. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9910112 · Cited by 280
Consensus Document on the Overlap Phenotype COPD–Asthma in COPD
Soler-Cataluña, J. J., Cosío, B., Izquierdo, J. L., López-Campos, J. L., Marín, J. M., Agüero, R., Baloira, A., Carrizo, S., Esteban, C., Galdiz, J. B., et al. (2012) · Archivos de Bronconeumología (English Edition) · doi:10.1016/j.arbr.2012.06.017 · Cited by 265
Hansel, T. T., Kharitonov, S. A., Donnelly, L. E., Erin, E. M., Currie, M. G., Moore, W. M., Manning, P. T., Recker, D. P., & Barnes, P. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0633fje · Cited by 208
Host defense function of the airway epithelium in health and disease: clinical background
Message, S. D., & Johnston, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703315 · Cited by 159
Metadata
- Authors
- Rutgers, S. R., van der Mark, T. W., Coers, W., Moshage, H., Timens, W., Kauffman, H. F., Koeter, G. H., & Postma, D. S.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1999-07-01
- Volume
- 54
- Issue
- 7
- Pages
- 576-580
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2164066820
- Cited by
- 125
- References
- 2
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.